Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
PBSV
$0.58
$
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Beta
0.699
Average Volume
Market Cap
Last Dividend
CIK
0001304161
ISIN
US71711N1000
CUSIP
71711N100
CEO
Victor Sanchez
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full Time Employees
75
IPO Date
2007-05-07
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Pharma-Bio Serv Announces Full Year Results and Special Dividend | DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2025 were approximately $9.0 million, a decrease of approximately $0.5 million when compared to last year. Additionally, a net loss for the year ended October 31, 2025 was reported of approximately $0.1 million, an improvement of approximately $0.7 million when compared to last year. | Accesswire | 2026-01-29 17:00:00 |
| Analyzing Pharma-Bio Serv (OTCMKTS:PBSV) and ATIF (NASDAQ:ZBAI) | ATIF (NASDAQ: ZBAI - Get Free Report) and Pharma-Bio Serv (OTCMKTS:PBSV - Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation. Risk and Volatility ATIF has a beta | Defense World | 2026-01-07 02:00:50 |
| ATIF (NASDAQ:ZBAI) and Pharma-Bio Serv (OTCMKTS:PBSV) Financial Analysis | Pharma-Bio Serv (OTCMKTS:PBSV - Get Free Report) and ATIF (NASDAQ: ZBAI - Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability. Earnings and Valuation This table compares Pharma-Bio | Defense World | 2026-01-02 02:26:47 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 8-K | 2026-01-29 | 2026-01-29 | View Filing |
| 10-K | 2026-01-29 | 2026-01-29 | View Filing |
| 4 | 2026-01-14 | 2026-01-14 | View Filing |
| 4 | 2026-01-14 | 2026-01-14 | View Filing |
| 4 | 2026-01-14 | 2026-01-14 | View Filing |
| 4 | 2026-01-14 | 2026-01-14 | View Filing |
| 8-K | 2025-09-15 | 2025-09-15 | View Filing |
| 10-Q | 2025-09-15 | 2025-09-15 | View Filing |
| 8-K | 2025-06-16 | 2025-06-16 | View Filing |
| 10-Q | 2025-06-16 | 2025-06-16 | View Filing |
| 8-K | 2025-05-16 | 2025-05-16 | View Filing |
| ARS | 2025-04-21 | 2025-04-21 | View Filing |
| DEF 14A | 2025-04-21 | 2025-04-21 | View Filing |
| 8-K | 2025-03-17 | 2025-03-17 | View Filing |
| 10-Q | 2025-03-17 | 2025-03-17 | View Filing |
| 10-K/A | 2025-02-28 | 2025-02-28 | View Filing |
| 8-K | 2025-01-29 | 2025-01-29 | View Filing |
| 8-K | 2025-01-29 | 2025-01-29 | View Filing |
| 10-K | 2025-01-29 | 2025-01-29 | View Filing |
| 4 | 2025-01-14 | 2025-01-14 | View Filing |
| 4 | 2025-01-14 | 2025-01-14 | View Filing |
| 4 | 2025-01-14 | 2025-01-14 | View Filing |
| 4 | 2025-01-14 | 2025-01-14 | View Filing |
| 8-K | 2024-09-16 | 2024-09-16 | View Filing |
| 10-Q | 2024-09-16 | 2024-09-16 | View Filing |
| 8-K | 2024-06-14 | 2024-06-14 | View Filing |
| 10-Q | 2024-06-14 | 2024-06-14 | View Filing |
| 8-K | 2024-05-02 | 2024-05-02 | View Filing |
| ARS | 2024-04-08 | 2024-04-08 | View Filing |
| DEF 14A | 2024-04-08 | 2024-04-08 | View Filing |
| 8-K | 2024-03-18 | 2024-03-18 | View Filing |
| 10-Q | 2024-03-18 | 2024-03-18 | View Filing |
| 10-K/A | 2024-02-28 | 2024-02-28 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|